Phuong Jean Pham: Cellens Inc partnering with Bruker JPK BioAFM to advance mechanobiology and AI for non-invasive cancer detection
Phuong Jean Pham, Co-Founder & CEO at Cellens Inc, made the following post on LinkedIn:
“Proud to announce Cellens Inc‘s strategic partnership with Bruker JPK BioAFM to advance mechanobiology and AI for non-invasive cancer detection! It is pretty rare today to see a completely new modality being invented and developed specifically for in vitro diagnostics. It is even rarer to find a partner that is so complementary to our strengths and capability to accelerate the scale-up of our cancer Dx platform. Patients can’t wait and we have to work faster and smarter, together!
Grateful for the commitment, resources, and effort that both sides have demonstrated to advance and drive our innovation forward! Stay tuned for more updates as we unveil our newest clinical feasibility data in the coming months. Onwards!”
Read further.
Source: Phuong Jean Pham/LinkedIn
.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023